Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT NO. 6 TO FORM S-1 - Rib-X Pharmaceuticals, Inc. | d255425ds1a.htm |
| EX-1.1 - FORM OF UNDERWRITING AGREEMENT - Rib-X Pharmaceuticals, Inc. | d255425dex11.htm |
| EX-5.1 - OPINION OF MINTZ,LEVIN,COHN,FERRIS,GLOVSKY AND POPEO, P.C. - Rib-X Pharmaceuticals, Inc. | d255425dex51.htm |
| EX-3.1.2 - CERTIFICATE OF AMENDMENT - Rib-X Pharmaceuticals, Inc. | d255425dex312.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Amendment No. 6 to the Registration Statement on Form S-1 of Rib-X Pharmaceuticals, Inc. of our report dated March 2, 2012, except for the reverse stock split described in Note 1 as to which the date is May 1, 2012, relating to the financial statements of Rib-X Pharmaceuticals, Inc., which appears in such Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Hartford, Connecticut
May 1, 2012